A carregar...
Innovations in oligonucleotide drug delivery
Oligonucleotides (ONs) are a new class of therapeutic compounds under investigation for the treatment of a variety of disease states, such as cancer and HIV, and for FDA approval of an anti‐CMV retinitis antisense molecule (Vitravene™, Isis Pharmaceuticals). However, these molecules are limited not...
Na minha lista:
| Publicado no: | J Pharm Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Subscription Services, Inc., A Wiley Company
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7094321/ https://ncbi.nlm.nih.gov/pubmed/12884243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.10399 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|